Professional Documents
Culture Documents
Baltimore's Noxilizer announces FDA 510(k) clearance of a medical device sterilized using
the company's nitrogen dioxide sterilization process.
Germantown's Senseonics, developing a long-term, implantable continuous glucose
monitoring system, signs exclusive distribution agreement with Roche.
Rockville's MacroGenics presents data from Phase 1 study of MGD010 at EULAR 2016.
Baltimore's WellDoc announces positive results regarding use of its digital health product
and also expands its leadership team with roster of seasoned healthcare executives.
Gaithersburg's Vtesse advances Phase 2b/3 clinical trial of VTS-270 in Niemann-Pick Type
C1 Disease.
Rockville's CASI Pharmaceuticals receives approval from CFDA to conduct Phase 2
clinical trials with ENMD-2076 for Fibrolamellar Carcinoma (FLC).
Germantown's Epigenomics' Epi proColon test--the first and only FDA approved blood test
for colon cancer, is included now in the USPSTF guidelines for colorectal cancer screening.
Baltimore's Clear Guide Medical recieves a patent for its innovation image fusion product.
Rockville's ABL and REGENXBIO to manufacture HoFH treatment for human clinical trials.
Columbia's Osiris' Grafix demonstrates superior clinical outcomes compared with EpiFix.
Baltimore's eNeura, Inc. receives CE Mark label extension expanding use of SpringTMS to
include migraine prevention.
Rockville's REGENXBIO and Biogen enter exclusive license agreement for the
development of gene therapy treatments for rare genetic vision disorders.
Poolesville High School senior Anantha Sriya Reddy wins MD BioGENEius contest. .
Baltimore's Sonavex named ICOY Life Sciences Company of the year.
animal and human health, health IT, research tools, and related technologies.
ABOUT MARYLAND
START A BUSINESS
MOVE A BUSINESS